COVID-19 Update | April 17, 2020

COVID-19 News

COVID-19 Update | April 17, 2020

April 17, 2020

As circumstances around coronavirus (COVID-19) continue to evolve quickly, the California Biotechnology Foundation wants to keep you informed about the progress being made by biotechnology researchers in California and across the nation to expand available testing, treat the virus and prevent its spread.

The following resources track what progress has been made as of April 17, 2020. Notable advancements include:

  • Remdesivir, an experimental antiviral drug made by the Bay Area’s Gilead Sciences, reportedly had a successful clinical trial in Chicago.
  • Johnson & Johnson is aiming to produce up to 900 million doses of its potential coronavirus vaccine by April 2021.
  • Biogen, Inc., Broad Institute of MIT and Harvard, and Partners Healthcare announced a consortium to build and share a COVID-19 biobank of biological and medical data to advance research for potential vaccines and treatments.

Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new CABiotech.org

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or patty.cooper@cabiotech.org.